Papers
7
Total Citations
148
H-Index
6
About
Jason Farrow is a leading researcher in urologic oncology and robotic surgery, whose work has significantly advanced the treatment of upper tract urothelial carcinoma (UTUC). His major contributions center on optimizing surgical outcomes through large-scale collaborative analyses, most notably as a key member of the ROBUUST (RObotic surgery for Upper Tract Urothelial Cancer Study) collaborative group. Farrow’s landmark multicenter study comparing robotic versus laparoscopic nephroureterectomy, cited 58 times, established a “tetrafecta” of outcomes that has reshaped surgical standards. His subsequent work on lymph node dissection (29 citations) and variant histology (17 citations) further refined risk stratification and treatment protocols for UTUC patients. Beyond clinical oncology, Farrow has pioneered the integration of human factors engineering into robotic surgery, developing adaptive automation systems that monitor surgeon cognitive workload in real time. His 2023 study on physiological metrics of surgical difficulty (19 citations) and his semi-autonomous suction tool demonstration (13 citations) represent groundbreaking steps toward safer, more intuitive human-robot interaction in the operating room. With additional contributions on perioperative chemotherapy trends and robotic pyeloplasty outcomes, Farrow’s work—garnering over 140 citations across his most-cited papers—positions him at the forefront of both surgical innovation and patient-centered urologic care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7